GSGiuseppe Sofo

Giuseppe Sofo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Giuseppe Sofo has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration

    by Andrea Pagani, Dominik Thor, Adriana C. Panayi, Silvan M. Klein, Sebastian Geis, Leonard Knoedler, Samuel Knoedler, Filippo A. G. Perozzo, Giuseppe Sofo, Rafael Loucas, et al.

    Autoimmune-induced alopecia, such as alopecia areata, involves immune-mediated damage to hair follicles, leading to significant hair loss. Emerging therapies that stabilize hypoxia-inducible factor 1-alpha (HIF-1α) show promise in counteracting follicular degradation and supporting hair regrowth. This communication highlights the potential of iron chelators, specifically deferoxamine (DFO) and deferiprone (DFP), to stabilize HIF-1α by reducing iron availability, thereby promoting vascularization, cellular proliferation, and a regenerative environment in the hair follicle niche. Clinical trials with iron chelators demonstrated improvements in hair density, thickness, and elasticity, as well as a reduction in hair loss by up to 66.8% over six months. These findings underscore the therapeutic potential of iron chelators in autoimmune alopecia management. Future research should explore the synergistic use of iron chelators with immune-modulating therapies, positioning them as viable options in the evolving field of alopecia treatment.


  • Top Cited Papers
    Open Access

    ChatGPT’s Response Consistency: A Study on Repeated Queries of Medical Examination Questions

    by Paul F. Funk, Cosima C. Hoch, Samuel Knoedler, Leonard Knoedler, Sebastian Cotofana, Giuseppe Sofo, Ali Bashiri Dezfouli, Barbara Wollenberg, Orlando Guntinas-Lichius, Michael Alfertshofer

    (1) Background: As the field of artificial intelligence (AI) evolves, tools like ChatGPT are increasingly integrated into various domains of medicine, including medical education and research. Given the critical nature of medicine, it is of paramount importance that AI tools offer a high degree of reliability in the information they provide. (2) Methods: A total of n = 450 medical examination questions were manually entered into ChatGPT thrice, each for ChatGPT 3.5 and ChatGPT 4. The responses were collected, and their accuracy and consistency were statistically analyzed throughout the series of entries. (3) Results: ChatGPT 4 displayed a statistically significantly improved accuracy with 85.7% compared to that of 57.7% of ChatGPT 3.5 (p < 0.001). Furthermore, ChatGPT 4 was more consistent, correctly answering 77.8% across all rounds, a significant increase from the 44.9% observed from ChatGPT 3.5 (p < 0.001). (4) Conclusions: The findings underscore the increased accuracy and dependability of ChatGPT 4 in the context of medical education and potential clinical decision making. Nonetheless, the research emphasizes the indispensable nature of human-delivered healthcare and the vital role of continuous assessment in leveraging AI in medicine.


  • Surgical management of breast fat necrosis: Multi-institutional data analysis of early outcomes and risk factors for complications

    by Samuel Knoedler, Leonard Knoedler, Heli Patel, Fortunay H. Diatta, Justin M. Camacho, Giuseppe Sofo, Filippo A.G. Perozzo, Brogan Evans, Vikram G. Mookerjee, Haripriya S. Ayyala, et al.